Enhanced NTPDase and 5′-nucleotidase activities in diabetes mellitus and iron-overload model

Molecular and Cellular Biochemistry

Volumn 298, Issue 1-2, 2007, Pages 101-107

  Miron, Vinícius Ribas ^a   Bauermann, Liliane ^a   Morsch, André Luis Bittencourt ^a   Zanin, Rafael Fernandes ^a   Corrêa, Maísa ^a   Silva, Adriane Cismoski ^a   Mazzanti, Cínthia ^a   Morsch, Vera Maria ^a   Lunkes, Gilberto Ignácio ^a   Schetinger, Maria Rosa Chitolina ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

5 nucleotidase; Diabetes; Iron overload; NTPDase; Nucleotide hydrolysis

Indexed keywords

5' NUCLEOTIDASE; ADENINE NUCLEOTIDE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; ALLOXAN; CITRIC ACID; DEOXYCYTIDINE KINASE; GLUCOSE; HEMOGLOBIN; IRON; IRON DEXTRAN; SODIUM CHLORIDE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME SUBSTRATE; GLUCOSE BLOOD LEVEL; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; HYDROLYSIS; IN VITRO STUDY; IRON BLOOD LEVEL; IRON OVERLOAD; MALE; NONHUMAN; PATHOPHYSIOLOGY; RAT; THROMBOCYTE FUNCTION; THROMBOCYTE RICH PLASMA;

RATTUS;

EID: 34247274174     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-006-9357-6     Document Type: Article

References (39)

1. American Diabetes Association Position Statement (2006) Diagnosis and classification of diabetes mellitus. Diabetes Care 29(1):S43-S48
2. Ouviña SO, La Greca RD, Zanaro NL, Palmer L, Sassetti B (2001) Endothelial dysfunction, nitric oxide and platelet activation in hypertensive and diabetic type II patients. Thromb Res 102:107-114
3. Srivastava S, Joshi CS, Sethi PP, Agrawal AK, Srivastava SK, Seth PK (1994) Altered platelet functions in non-insulin-dependent diabetes mellitus (NIDDM). Thromb Res 76:451-461
4. Kim SW, Ryu GH, Lee I, Koh JJ, Min BG, Lee HK (1995) Adhered platelet morphology in diabetes mellitus. Diabetes Metab 21:50-53
5. Mazzanti L, Mutus B (1997) Diabetes induced alterations in platelet metabolism. Clin Biochem 30:509-515
6. Hekimsoy Z, Payzin B, Ornek T, Kandogan G (2002) Mean platelet volume in Type 2 diabetic patients. J Diabetes Complicat 18:173-176
7. Volonté C, Amadio S, D'Ambrosi N, Colpi M, Burnstock G (2006) P2 receptor web: Complexoty and fine-tuning. Pharmacol Therap 112:264-280
8. Pilla C, Emanuelli T, Frasseto SS, Battastini AMO, Dias RD, Sarkis JJF (1996) ATP diphosphohydrolase activity (apyrase, E.C.3.6.1.5) in human blood platelets. Platelets 7:225-230
9. Marcus AJ, Broekman MJ, Drosopoulos JHF, Islam N, Pinsky DJ, Sesti C, Levi R (2003) Heterologous cell-cell interaction: Thromboregulation, cerebroprotection and cardioprotection by CD39 (NTPDase-1). J Thromb Haemost 1:2497-2509
10. Atkinson B, Dwyer K, Enjyoji K, Robson S (2006) Ecto-nucleotidases of the CD39/NTPDase family modulate platelet activation and thrombus formation: Potential as therapeutic targets. Blood Cell Mol Dis (BCMD) 36(2):217-222
11. Enjyoji J, Sévigny J, Lin Y, Frenette PS, Christie PD, Esch JS 2nd, Imai M, Edelburg JM, Rayburn H, Lech M, Beeler DL, Csizmadia E, Wagner DD, Robson SC, Rosenberg RD (1999) Targeted disruption of cd39/ ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med 5:1010-1017
12. Sévigny J, Sundberg C, Braun N, Guckelberger O, Csizmadia E, Qawi I, Imai M, Zimmermann H, Robson S (2002) Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation. Blood 99:2801-2809
13. Matsuno H, Tokuda H, Ishisaki A, Zhou Y, Kitajima Y, Kozawa O (2005) P2Y12 receptors play a significant role in the development of platelet microaggregation in patients with diabetes. J Clin Endocr Metab 90(2):920-927
14. Stráter N (2006) Ecto-5′-nucleotidase: Structure function relationships. Purinergic Signalling 2:343-350
15. Hunsucker SA, Mitchell BS, Spychala J (2005) The 5′-nucleotidases as regulators of nucleotide and drug metabolism. Pharmacol Therap 107:1-30
16. Zimmermann H (1999) Two novel families of ecto-nucleotidases: Molecular structures, catalytic properties and a search for function. Trends Pharmacol Sci 2:231-236
17. Lunkes GI, Lunkes D, Stefanello F, Morsch A, Morsch VM, Mazzanti CM, Schetinger MRC (2003) Enzymes that hydrolyze adenine nucleotides in diabetes and associated pathologies. Thromb Res 109:189-194
18. Kitakaze M, Hori M, Sato H, Takashima S, Inoue M, Kitabatake A, Kamada T (1991) Endogenous adenosine inhibits platelet aggregation during myocardial ischemia in dogs. Circ Res 69:1402-1408
19. Kawashima Y, Nagasawa T, Ninomiya H (2000) Contribution of ecto-5′-nucleotidase to the inhibition of platelet aggregation by human endothelial cells. Blood 96:2157-2162
20. Lesnefsky EJ (1994) Tissue iron overload and mechanisms of iron catalyzed oxidative injury. Adv Exp Med Biol 366:129-146
21. Halliwell B, Gutteridge JMC (1999) Antioxidants in nutrition, health and disease. Oxford University Press, New York, 143 pp
22. Ellervik C, Mandrup-Poulsen T, Nordestgaard BG, Larsen LE, Appleyard M, Frandsen M, Petersen P, Schlichting P, Saermark T, Tybjaerg-Hansen A, Birgens H (2001) Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: A retrospective study. Lancet 358:1405-1409
23. Limdi JK, Crampton JR (2004) Hereditary haemocromatosis. QJM Int J Med 97:315-324
24. Marx JJM (2002) Prevention of organ failure in hereditary haemochromatosis. Neth J Med 60(11):419-422
25. Praticó D, Pasin M, Barry OP, Ghiselli A, Sabatino G, Iuliano L, Fitzgerald GA, Violi F (1999) Iron-dependent human platelet activation and hydroxyl radical formation. Circulation 22:3118-3124
26. Kadikoylu G, Yavasoglu I, Bolaman Z, Senturk T (2006) Platelet parameters in women with iron deficiency anemia. J Natl Med Assoc 98(3):398-402
27. Hannuksela J, Parkkila S, Waheed A, Britton RS, Fleming RE, Bacon BR, Sly WS (2003) Human platelets express hemochromatosis protein (HFE) and transferring receptor 2. Eur J Haematol 70:201-206
28. Lunkes GI, Lunkes D, Morsch VM, Mazzanti CM, Morsch ALB, Miron VR, Schetinger MRC (2004) NTPDase and 5′-nucleotidase activities in rats with alloxan-induced diabetes. Diabetes Res Clin Pract 65:1-6
29. Malaisse WJ, Malaisse-Lagae F, Sener A, Pipeleers DG (1982) Determinations of the selective toxicity of alloxan to the pancreatic B cell. PNAS - USA 79:927-930
30. Pucheu S, Coudray C, Tresallet N, Favier A, de Leiris J (1993) Effect of iron overload in the isolated ischemic and reperfused rat hearth. Cardiovasc Drug Ther 7:701-711
31. Chan K, Delfert D, Junger KD (1986) A direct colorimetric method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 157:375-380
32. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantity of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
33. Pinsky DJ, Broekman MJ, Peschon JJ, Stocking KL, Fujita T, Ramasamy R, Connolly ES Jr, Huang J, Kiss S, Zhang Y, Choudhri TF, McTaggart RA, Liao H, Drosopoulos JH, Price VL, Marcus AJ, Maliszewski CR (2002) Elucidation of the thromboregulation role of CD39/ectoapyrase in the ischemic brain. J Clin Invest 109(8):1031-1040
34. Birk AV, Broekman MJ, Gladek EM, Robertson HD, Drosopoulos JHF, Marcus AJ, Szeto HH (2002) Role of extracellular ATP metabolism in regulation of platelet reactivity. J Lab Clin Med 140:166-175
35. Zimmermann H (1999) Nucleotides CD39: Principal modulatory players in haemostasis and thrombosis. Nat Med 5:987-988
36. Barcellos CK, Schetinger MRC, Battastini AMO, Silva LB, Dias RD, Sarkis JJF (1994) Inhibitory effect of cadmium acetate on synaptosomal ATP diphospohydrolase (EC 3.6.1.5); apyrase) from adult rat cerebral cortex. Braz J Med Biol Res 27:1111-1115
37. Schetinger MRC, Wyse ATS, Silva LB, Barcellos CK, Dias RD, Sarkis JJF (1995) Effects of aluminum chloride on the kinetics of rat cortex synaptosomal ATP diphosphohydrolase (EC 3.6.1.5). Biol Trace Elem Res 50:209-219
38. Moretto MB, Lermen CL, Morsch VM, Bohrer D, Ineu RP, Silva AC, Balz D, Schetinger MRC (2003) Effect of subchronic treatment with mercury chloride on NTPDase, 5′-nucelotidase and acetylcholinesterase from cerebral cortex of rats. J Trace Elem Med Biol 17(4): 255-260
39. Zimmermann H (2001) Ectonucleotidases: Some recent developments and note on nomenclature. Drug Dev Res 52:44-56